Law and Moral Enhancement:
A lecture by Julian Savulescu

Tuesday, October 20, 2015 12:00 PM
Lectures and Panels
2015-2016

Julian Savulescu is Uehiro Chair in Practical Ethics, Director of The Oxford Centre for Neuroe...

Read More

2015 Petrie-Flom Center Annual Open House

Monday, September 28, 2015 5:30 PM
Lectures and Panels
2015-2016
HLS Pub, Wasserstein Hall, 1st floor
1585 Massachusetts Ave., Cambridge, MA

Come learn more about what the Petrie-Flom Center does and how you can get involved at this ga...

Read More

This is Your Brain on Human Rights: Moral Enhancement and Human Rights

Harvard Law School, May 26, 2015
by I. Glenn Cohen (Faculty Director)

Faculty Director I. Glenn Cohen has authored a new paper on the use of moral enhacement t...

Read More

Hospitals Find New Ways to Monitor Patients 24/7:

Wall Street Journal, May 25, 2015
by Laura Landro

Hospitals are trying new early-warning systems to monitor patients for subtle but dangerous signs o...

Read More

U.S. Introduces New DNA Standard for Ensuring Accuracy of Genetic Tests

New York Times, May 14, 2015
by Robert Pear

WASHINGTON — The federal government opened the door to a new era of genetic medicine on Thurs...

Read More

Call for $2bn global antibiotic research fund

BBC News, May 14, 2015
by Fergus Walsh

The global pharmaceutical industry is being called on to pay for a $2bn (£1.3bn) innovation f...

Read More

Drug Costs Top $50K A Year For Half Million Americans

Forbes, May 13, 2015
by Bruce Japsen

With the drug industry launching more expensive targeted therapies, the number of Americans with an...

Read More

Apple Has Plans for Your DNA:

MIT Technology Review, May 5, 2015
by Antonio Regalado

Of all the rumors ever to swirl around the world’s most valuable company, this may be the fir...

Read More

DNA Sequencing Market Will Exceed $20 Billion, Says Illumina CEO Jay Flatley

Forbes, April 29, 2015
by Luke Timmerman

Illumina, one of the most important companies in biomedicine, is still barely known to the public....

Read More

Fall 2015 Course: Drug Product Liability Litigation

...

Fall 2015 Course: Drug Product Liability Litigation
Harvard Law School

Deadline: Waitlist processing will run from Monday, May 18, 2015 through Friday, June 26, 2015.

Drug Product Liability Litigation

Mr. Peter Grossi
Fall 2015 Course
Meets: T, W 5:00pm - 7:00..
.

Read More

Critics Lash Out At Chinese Scientists Who Edited DNA In Human Embryos

NPR, April 23, 2015
by Rob Stein

For the first time, scientists have edited DNA in human embryos, a highly controversial step long c...

Read More

Innovation Law and Policy:

U. C. Davis Law Review, Forthcoming 2016
by Rachel E. Sachs

Academic Fellow Rachel E. Sachs has a new article forthcoming in 2016 on law and the future of pers...

Read More

Meet Pharma’s Newest Movers and Shakers:

Wall Street Journal, April 22, 2015
by Jonathan D. Rockoff and Joseph Walker

A few years ago, the drug companies dominating mergers-and-acquisitions headlines were largely hous...

Read More

NOW ONLINE: I. Glenn Cohen Discusses Modern Fertility Technologies and Benefits

Chronicle (WCVB/ABC Boston), April 13, 2015
by Shayna Seymour, interviewing I. Glenn Cohen (Faculty Director)

Show Abstract: The birds and the bees are still important – but today's couples eage...

Read More

Are trade secrets delaying biosimilars?

Science, April 10, 2015
by W. Nicholson Price II (Academic Fellow Alumnus) and Arti K. Rai

Petrie-Flom Academic Fellow alumnus Nicholson Price, now an Assistant Professor at the Un...

Read More

Transatlantic Lessons in Regulation of Mitochondrial Replacement Therapy:

Science, April 10, 2015
by I. Glenn Cohen (Faculty Director), with Eli Adashi and Julian Savulescu

Cambridge, Mass., April 9, 2015 – A paper forthcoming on Friday in Science discusses the regu...

Read More

Trio contrast approaches taken by Britain versus the US concerning mitochondrial replacement therapy

MedicalXpress, April 10, 2015
by Bob Yirka, citing I. Glenn Cohen (Faculty Director) et al.

Glenn Cohen, with Harvard University, Julian Savulescu, with the University of Oxford and Eli Adash...

Read More

Is UK evaluation of reproductive tech a model for US?

MedicalXpress, April 10, 2015
by David Orenstein, citing I. Glenn Cohen (Faculty Director) et al.

When the United Kingdom resoundingly approved mitochondrial replacement therapy in Februa...

Read More

“My Body, My Bank”

Texas Law Review, Vol. 93, No. 4, 2015
by I. Glenn Cohen (Faculty Director)

Abstract:      

This essay reviews Kara Swanson’s "Banking on...

Read More

Families Matter:
Ethically, Legally, and Clinically

Friday, March 20, 2015
Conferences
2014-2015
Harvard Medical School
Boston, MA

Program

We often talk, in bioethics, about individual autonomy. Yet our most challenging ethi...

Read More

Clinical Trial Recruitment: Problems, Misconceptions, and Possible Solutions,

Petrie-Flom Center, February 5, 2015

On January 19 - 21, 2015, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethic...

Read More

Third Annual Health Law Year in P/Review

Friday, January 30, 2015 7:45 AM - 5:00 PM
Conferences
2014-2015
Wasserstein Hall, Milstein East AB
1585 Massachusetts Avenue, Cambridge, MA

Couldn't make it in person? Check out the individual sessions in the videos linked above!

The...

Read More

The Future of Personalized Medicine

Hosted by The Future Society at the Harvard Kennedy School, January 28, 2015
by Rachel E. Sachs

On January 28, 2015, Academic Fellow Rachel E. Sachs spoke to the Future Society at the Harvard Ken...

Read More

Outbreak: Developing New Medical Products for Epidemics,
A lecture by Peter Hutt

Thursday, January 15, 2015 12:30 PM
Lectures and Panels
2014-2015
Hauser Hall 102
1575 Massachusetts Avenue, Cambridge, MA

Video of the lecture and following discussion are available online.

The recent outbreak of Ebola h...

Read More

First biosimilar drug set to enter US market:

Nature, January 13, 2015
by Heidi Ledford, quoting W. Nicholson Price II (Academic Fellow Alumnus)

[...] The FDA is expected to make a final decision by May. But even as Sandoz prepares to sell its...

Read More

The Changing Regulation of Laboratory-Developed Tests:

Genomic Medicine Case Conference (GMCC) at Massachusetts General Hospital, November 14, 2014
by Rachel Sachs (Academic Fellow)

On November 14, 2014, Academic Fellow Rachel Sachs delivered a talk on the topic of the FDA&rs...

Read More

2015 - 2017 Animal Law Academic Fellowship

...

2015 - 2017 Animal Law Academic Fellowship
Animal Advocacy Program, Harvard Law School

Deadline: January 19, 2015

The Animal Law Academic Fellowship is a two-year full-time residential program designed to ide...

Read More

Law and Ethics of Non-Invasive Prenatal Testing

Thursday, November 06, 2014 12:00 PM
Lectures and Panels
2014-2015
Wasserstein Hall, Room 3018
1585 Massachusetts Ave., Cambridge, MA

The Petrie-Flom Center hosted a discussion of the issues surrounding noninvasive prenatal testing (...

Read More

Regulating the Organ Market: Normative Foundations for Market Regulation

Social Science Research Network, November 03, 2014
by I. Glenn Cohen (Faculty Director)

Abstract:      

Should organs for transplant be bought and sold? The...

Read More

Emerging Issues and New Frontiers for FDA Regulation

Monday, October 20, 2014 8:00 AM - 5:00 PM
Conferences
2014-2015
Washington, DC

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law...

Read More

Freezing Eggs to Put off Pregnancy - Clever Business Move but Not Magic Bullet: Experts

Ria Novosti, quoting I. Glenn Cohen (Faculty Director), October 20, 2014

From the article:

[...] Although companies consider their offer to freeze eggs to be a benefit for...

Read More

Organs Without Borders? Allocating Transplant Organs, Foreigners, and the Importance of the Natio…

Social Science Research Network, October 19, 2014
by I. Glenn Cohen (Faculty Director)

Abstract:      

Most of the discussion of market or non-market forms...

Read More

​Nudging the FDA

The American Interest, October 17, 2014
by W. Nicholson Price II (Academic Fellow alumnus) and I. Glenn Cohen (Faculty Director)

From the article:

[...] The FDA’s regulation of drugs is frequently the subject of poli...

Read More

Egg freezing message: Lean in, and save the kids for later

The Boston Globe, October 16, 2014
by Joanna Weiss, quoting I. Glenn Cohen (Faculty Director)

From the article:

[...] Glenn Cohen, a professor at Harvard Law School, worries that an egg-freezi...

Read More

Legal and Ethical Issues in Healthcare Start-Ups
(followed by Petrie-Flom's 2014 Open House)

Monday, October 06, 2014 4:00 - 5:30 PM
Lectures and Panels
2014-2015
Wasserstein Hall, Milstein West AB
1585 Massachusetts Ave., 2nd floor, Cambridge, MA

New healthcare start-ups face a range of legal and ethical challenges as they develop new products...

Read More

I. Glenn Cohen and Holly F. Lynch (eds.): Human subjects research regulation: perspectives on the…

Theoretical Medicine and Bioethics, September 26, 2014
by Lydia Stewart Ferreira (Visiting Scholar)

Human Subjects Research (HSR) is an annual $10 billion dollar global activity. While there is conse...

Read More

A Fuller Picture of Organ Markets

The American Journal of Bioethics, September 17, 2014
by I. Glenn Cohen (Faculty Director)

From the article: 

[...] A different problem with the reliance on the Iranian data is th...

Read More

An Interview with I. Glenn Cohen on Controversial Health Issues

PBS.org, September 9, 2014
by Tavis Smiley, interviewing I. Glenn Cohen (Faculty Director)

In an interview with PBS.org, Faculty Director I. Glenn Cohen, sat down with Tavis Smiley to d...

Read More